You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
清晰醫療(01406.HK)公開發售獲超額認購6.17倍 發售價每股1.6港元
格隆匯 02-17 06:43

格隆匯2月17日丨清晰醫療(01406.HK)發佈公吿,公司全球發售1.36億股股份,其中香港發售股份1360萬股,國際發售股份1.224億股,另有15%超額配股權;發售價已釐定為每股發售股份1.6港元,每手買賣單位1250股;光大證券為獨家保薦人;預期股份將於2022年2月18日於聯交所主板掛牌上市。

香港公開發售項下初步提呈發售的發售股份已獲踴躍超額認購。已合共接獲8642份有效申請,認購合共8392.375萬股香港發售股份,相當於香港發售股份總數約6.17倍。國際發售股份已獲輕微超額認購,相當於國際發售項下初步可供認購的發售股份總數約1.13倍。

按發售價每股發售股份1.6港元計算,公司自全球發售收取的所得款項淨額估計約為1.773億港元。公司擬將全球發售所得款項淨額約44.8%用於在香港成立兩家新醫療中心以提供眼科服務;約30.5%將用於收購大灣區內選定城市的一至兩家眼科診所、眼科門診部或眼科醫院的多數及╱或少數權益;約14.7%將用於與合適的合作伙伴設立眼科診所以提供眼科醫療服務;及約10.0%將用於營運資金及其他一般企業用途。倘超額配股權獲悉數行使,公司將就行使超額配股權時將予發行及配發的2040萬股額外發售股份收取額外所得款項淨額約3080萬港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account